Evidence map›Paper›PMID 25086217›Full record

ArticleBiochimie2014

Inhibitory effects of a novel Val to Thr mutation on the distal heme of human catalase.

Zahra Mashhadi, William E Boeglin, Alan R Brash

Open access · greenAbstract read
In one paragraph

Article in Biochimie, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Zahra MashhadiDepartment of Pharmacology and the Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, TN 37232, USA.
William E BoeglinDepartment of Pharmacology and the Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, TN 37232, USA.
Alan R BrashDepartment of Pharmacology and the Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, TN 37232, USA. Electronic address: alan.brash@vanderbilt.edu.
Vanderbilt University · USVanderbilt Health · US

Funding

Novel Catalases and their ProductsR01GM074888 · NIGMS · VANDERBILT UNIVERSITY · PI BRASH, ALAN R. · 2006 to 2013
$2.4M
NIGMS NIH HHS GM-074888NIGMS NIH HHS R01 GM074888
6 · The paper itself

Abstract

True catalases efficiently breakdown hydrogen peroxide, whereas the catalase-related enzyme allene oxide synthase (cAOS) is completely unreactive and instead metabolizes a fatty acid hydroperoxide. In cAOS a Thr residue adjacent to the distal His restrains reaction with H2O2 (Tosha et al. (2006) J. Biol. Chem. 281:12610; De Luna et al. (2013) J. Phys. Chem. B 117: 14635) and its mutation to the consensus Val of true catalases permits the interaction. Here we investigated the effects of the reciprocal experiment in which the Val74 of human catalase is mutated to Thr, Ser, Met, Pro, or Ala. The Val74Thr substitution decreased catalatic activity by 3.5-fold and peroxidatic activity by 3-fold. Substitution with Ser had similar negative effects (5- and 3-fold decreases). Met decreased catalatic activity 2-fold and eliminated peroxidatic activity altogether, whereas the Val74Ala substitution was well tolerated. (The Val74Pro protein lacked heme). We conclude that the conserved Val74 of true catalases helps optimize catalysis. There are rare substitutions of Val74 with Ala, Met, or Pro, but not with Ser of Thr, possibly due their hydrogen bonding affecting the conformation of His75, the essential distal heme residue for activity in catalases.

Indexed as

Mutation, MissenseAmino Acid SequenceBiocatalysisCatalaseCatalytic DomainCrystallography, X-RayHemeHumansHydrogen BondingHydrogen PeroxideModels, MolecularMolecular StructureMutant ProteinsPeroxidesProtein Structure, TertiarySequence Homology, Amino AcidCatalaseHemeHydrogen PeroxideMutant ProteinsPeroxidesThreonineValineCatalatic activityHuman catalaseMutationPeroxidatic activityProximal hemeVal74

Identifiers

PMID25086217
PMCPMC4250446
OpenAlexW2088233132

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.